Study registry for targeted treatments in psoriasis patients
Treatments studied
Part of Bones, joints & muscles, Skin clinical trials.
This trial is a registry that collects information from adults with plaque psoriasis or psoriatic arthritis who are starting a new biologic or other systemic treatment. It helps researchers understand how these treatments are used in real life and what outcomes they may have.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve been diagnosed with plaque psoriasis or psoriatic arthritis by a dermatologist
- You are 18 years or older
- You are starting a specific new biologic (targeted shot/infusion) or other systemic medicine for the first time
- You can understand and consent to the study in German, French, Italian, and English
- You agree to take part (informed consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a psoriasis registry that records real-world information about people starting a systemic (whole-body) treatment for the first time. It helps doctors understand how these treatments work in everyday care and may improve future treatment decisions.
This registry collects information from adults with psoriasis to better understand how psoriasis affects people and how treatments are used in real life. It may help future research and improve knowledge about treatment patterns and outcomes.
This study follows patients with moderate to severe psoriasis who are starting a new advanced medication for the first time. Researchers will track how well the treatment works early on to understand what helps different patients improve.
This study follows people starting a new advanced psoriasis treatment to see how well it works over 16 weeks. You'll have three office visits with your dermatologist, and researchers will track your skin improvement to help understand which treatments work best for different patients.
This study is a registry that collects health information from adults with certain autoimmune conditions who are currently using (or have been recommended) biologic or DMARD medicines. It may help researchers better understand these diseases and how treatments affect people over time.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.